Roth MKM analyst Richard Baldry initiated coverage of Forian with a Buy rating and $5 price target. The firm, which calls Forian’s healthcare data-centric platform “a uniquely valuable Cloud Data Services franchise,” believes its recurring revenue model offers investors an attractive combination of organic growth and scaling profitability.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FORA: